IRadimed Corporation (IRMD) NASDAQ
89.86
-2.19(-2.38%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.24B |
| Enterprise Value | 1.19B |
| P/E Ratio | 48.65 |
| PEG Ratio | 2.63 |
| Price/Sales Ratio | 13.31 |
| Price/Book Ratio | 11.66 |
| Enterprise/Revenue | 12.66 |
| Enterprise/EBITDA | 35.76 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.27 |
| Operating Margin | 0.32 |
Management Effectiveness
| Return On Assets | 0.21 |
| Return On Equity | 0.24 |
Income Statement
| Revenue | 83.81M |
| Revenue/Share | 6.75 |
| Gross Profit | 64.32M |
| EBITDA | 28.53M |
| Net Income | 22.48M |
| Diluted EPS | 1.75 |
Balance Sheet
| Total Cash | 56.37M |
| Total Cash/Share | 4.41 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.13 |
| Book Value Per Share | 7.71 |
Price History
| 52-Week Change | 55.49 |
| 52-Week High | 107.9 |
| 52-Week Low | 55.11 |
| Moving Average 50 Days | 91.19 |
| Moving Average 200 Days | 88.72 |
Statistics
| Average Volume | 108,949 |
| Shares Outstanding | 12.78M |
| % Held by Institutions | 59.91 |
Dividend And Splits
| Trailing Annual Dividend Rate | 1.24 |
| Trailing Annual Dividend Yield | 1.38 |
| Payout Ratio | 0.65 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
